Chlorogenic acids inhibit glutamate dehydrogenase and decrease intracellular ATP levels in cultures of chick embryo retina cells

Biochemical Pharmacology
Ivan DomithMarcelo Cossenza

Abstract

Chlorogenic acids (CGAs) are a group of phenolic compounds found in worldwide consumed beverages such as coffee and green tea. They are synthesized from an esterification reaction between cinnamic acids, including caffeic (CFA), ferulic and p-coumaric acids with quinic acid (QA), forming several mono- and di-esterified isomers. The most prevalent and studied compounds are 3-O-caffeoylquinic acid (3-CQA), 4-O-caffeoylquinic acid (4-CQA) and 5-O-caffeoylquinic acid (5-CQA), widely described as having antioxidant and cell protection effects. CGAs can also modulate glutamate release from microglia by a mechanism involving a decrease of reactive oxygen species (ROS). Increased energy metabolism is highly associated with enhancement of ROS production and cellular damage. Glutamate can also be used as an energy source by glutamate dehydrogenase (GDH) enzyme, providing α-ketoglutarate to the tricarboxylic acid (TCA) cycle for ATP synthesis. High GDH activity is associated with some disorders, such as schizophrenia and hyperinsulinemia/hyperammonemia syndrome. In line with this, our objective was to investigate the effect of CGAs on GDH activity. We show that CGAs and CFA inhibits GDH activity in dose-dependent manner, reaching complete...Continue Reading

References

Jan 1, 1991·Radiation and Environmental Biophysics·M LangH K Lichtenthaler
Jun 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·K MoonE L Smith
Mar 17, 2001·Nature Reviews. Neuroscience·F J Livesey, C L Cepko
Sep 19, 2002·Journal of Agricultural and Food Chemistry·M NardiniC Scaccini
Jun 6, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gulnur Sh BurbaevaElena B Tereshkina
Oct 23, 2003·Neurochemical Research·R Paes-de-CarvalhoJ M Ferreira
Jan 11, 2005·The American Journal of Clinical Nutrition·Claudine ManachChristian Rémésy
Feb 16, 2006·The Journal of Biological Chemistry·Changhong LiThomas J Smith
Mar 7, 2006·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Pervin K IseriNurşen Yüksel
Oct 13, 2006·Journal of Neurochemistry·Carole EscartinGilles Bonvento
Sep 22, 2007·The Journal of Nutrition·Mariana MonteiroCarmen Donangelo
Nov 28, 2007·Neurology·M PulickenP A Calabresi
Jun 25, 2008·Multiple Sclerosis : Clinical and Laboratory Research·J ToledoP Villoslada
Nov 22, 2008·The Journal of Nutrition·Adriana FarahSophie Lafay
Jul 1, 2008·Environmental Toxicology and Pharmacology·Yongjin LiYong Li
Sep 29, 2011·Diabetes·Leonard A Fahien, Michael J Macdonald
Aug 1, 2010·Nutrients·Daniele Del RioAlan Crozier
Jun 29, 2012·Neural Development·M Natalia Vergara, M Valeria Canto-Soler
Nov 21, 2012·Nature Reviews. Neurology·Anat LondonMichal Schwartz
Mar 20, 2013·Molecular Aspects of Medicine·Matthias A HedigerElspeth A Bruford
Jan 18, 2014·Neurochemical Research·Cleanthe SpanakiAndreas Plaitakis
May 16, 2014·Molecular Neurobiology·Vishal Jindal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here